Literature DB >> 29295841

In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction.

Eleni Tholouli1, Katherine Sturgess2, Rachel E Dickinson2, Andrew Gennery2,3, Andrew J Cant2,3, Graham Jackson3,4, Jim Lordan3, Sophie Hambleton2,3, Mary A Slatter3, Venetia Bigley2,3, Matthew Collin2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29295841      PMCID： PMC5992650          DOI： 10.1182/blood-2017-10-811489

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.

Authors:  Csaba Bödör; Aline Renneville; Matthew Smith; Aurélie Charazac; Sameena Iqbal; Pascaline Etancelin; Jamie Cavenagh; Michael J Barnett; Karolina Kramarzová; Biju Krishnan; András Matolcsy; Claude Preudhomme; Jude Fitzgibbon; Carolyn Owen
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

Authors:  Ronjon Chakraverty; Karl Peggs; Rajesh Chopra; Donald W Milligan; Panagiotis D Kottaridis; Stephanie Verfuerth; Johanne Geary; Dharsha Thuraisundaram; Kate Branson; Suparno Chakrabarti; Premini Mahendra; Charles Craddock; Anne Parker; Ann Hunter; Geoff Hale; Herman Waldmann; Catherine D Williams; Kwee Yong; David C Linch; Anthony H Goldstone; Stephen Mackinnon
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

Authors:  Jennifer Cuellar-Rodriguez; Juan Gea-Banacloche; Alexandra F Freeman; Amy P Hsu; Christa S Zerbe; Katherine R Calvo; Jennifer Wilder; Roger Kurlander; Kenneth N Olivier; Steven M Holland; Dennis D Hickstein
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

4.  Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease.

Authors:  Markus Maeurer; Isabelle Magalhaes; Jan Andersson; Per Ljungman; Erik Sandholm; Michael Uhlin; Jonas Mattsson; Olle Ringdén
Journal:  Transplantation       Date:  2014-12-27       Impact factor: 4.939

5.  Timely follow-up of a GATA2 deficiency patient allows successful treatment.

Authors:  Sara Ciullini Mannurita; Marina Vignoli; Gloria Colarusso; Fabio Tucci; Marinella Veltroni; Stefano Frenos; Veronica Tintori; Maurizio Aricò; Venetia Bigley; Matthew Collin; Claudio Favre; Eleonora Gambineri
Journal:  J Allergy Clin Immunol       Date:  2016-07-29       Impact factor: 10.793

6.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Authors:  Beatriz E Marciano; Chiung-Yu Huang; Gyan Joshi; Nima Rezaei; Beatriz Costa Carvalho; Zoe Allwood; Aydan Ikinciogullari; Shereen M Reda; Andrew Gennery; Vojtech Thon; Francisco Espinosa-Rosales; Waleed Al-Herz; Oscar Porras; Anna Shcherbina; Anna Szaflarska; Şebnem Kiliç; Jose L Franco; Andrea C Gómez Raccio; Persio Roxo; Isabel Esteves; Nermeen Galal; Anete Sevciovic Grumach; Salem Al-Tamemi; Alisan Yildiran; Julio C Orellana; Masafumi Yamada; Tomohiro Morio; Diana Liberatore; Yoshitoshi Ohtsuka; Yu-Lung Lau; Ryuta Nishikomori; Carlos Torres-Lozano; Juliana T L Mazzucchelli; Maria M S Vilela; Fabiola S Tavares; Luciana Cunha; Jorge A Pinto; Sara E Espinosa-Padilla; Leticia Hernandez-Nieto; Reem A Elfeky; Tadashi Ariga; Heike Toshio; Figen Dogu; Funda Cipe; Renata Formankova; M Enriqueta Nuñez-Nuñez; Liliana Bezrodnik; Jose Gonçalo Marques; María I Pereira; Viviana Listello; Mary A Slatter; Zohreh Nademi; Danuta Kowalczyk; Thomas A Fleisher; Graham Davies; Bénédicte Neven; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2014-04       Impact factor: 10.793

7.  Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.

Authors:  Aloysius Y L Ho; Antonio Pagliuca; Michelle Kenyon; Jane E Parker; Aleksandar Mijovic; Stephen Devereux; Ghulam J Mufti
Journal:  Blood       Date:  2004-04-01       Impact factor: 22.113

8.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.

Authors:  Rachel Emma Dickinson; Helen Griffin; Venetia Bigley; Louise N Reynard; Rafiqul Hussain; Muzlifah Haniffa; Jeremy H Lakey; Thahira Rahman; Xiao-Nong Wang; Naomi McGovern; Sarah Pagan; Sharon Cookson; David McDonald; Ignatius Chua; Jonathan Wallis; Andrew Cant; Michael Wright; Bernard Keavney; Patrick F Chinnery; John Loughlin; Sophie Hambleton; Mauro Santibanez-Koref; Matthew Collin
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

9.  GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.

Authors:  Matthias Griese; Ralf Zarbock; Ulrich Costabel; Jenna Hildebrandt; Dirk Theegarten; Michael Albert; Antonia Thiel; Andrea Schams; Joanna Lange; Katazyrna Krenke; Traudl Wesselak; Carola Schön; Matthias Kappler; Helmut Blum; Stefan Krebs; Andreas Jung; Carolin Kröner; Christoph Klein; Ilaria Campo; Maurizio Luisetti; Francesco Bonella
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

10.  Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease.

Authors:  Gwilym Webb; Yung-Yi Chen; Ka-Kit Li; Desley Neil; Ye Htun Oo; Alex Richter; Venetia Bigley; Matthew Collin; David H Adams; Gideon M Hirschfield
Journal:  J Hepatol       Date:  2016-01-23       Impact factor: 25.083
View more
  11 in total

1.  Donor-derived MDS/AML in families with germline GATA2 mutation.

Authors:  Pallavi Galera; Amy P Hsu; Weixin Wang; Stephenie Droll; Rui Chen; Jason R Schwartz; Jeffery M Klco; Sally Arai; Luke Maese; Christa Zerbe; Mark J Parta; Neal S Young; Steven M Holland; Dennis D Hickstein; Katherine R Calvo
Journal:  Blood       Date:  2018-09-19       Impact factor: 22.113

2.  HSCT for GATA2 deficiency across the pond.

Authors:  Dennis Hickstein
Journal:  Blood       Date:  2018-03-22       Impact factor: 22.113

3.  Can somatic GATA2 mutation mimic germ line GATA2 mutation?

Authors:  Mallika Sekhar; Rachael Pocock; David Lowe; Christopher Mitchell; Teresa Marafioti; Rachel Dickinson; Matthew Collin; Marc Lipman
Journal:  Blood Adv       Date:  2018-04-24

4.  MonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Maria Francisca Moraes-Fontes; Íris Caramalho; Amy P Hsu; Steven M Holland; Manuel Abecasis
Journal:  J Clin Immunol       Date:  2018-11-26       Impact factor: 8.317

Review 5.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 6.  Germline Predisposition to Hematolymphoid Neoplasia.

Authors:  Olga K Weinberg; Frank Kuo; Katherine R Calvo
Journal:  Am J Clin Pathol       Date:  2019-08-01       Impact factor: 2.493

7.  Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.

Authors:  Inga Hofmann; Serine Avagyan; Alyssa Stetson; Dongjing Guo; Hasan Al-Sayegh; Wendy B London; Leslie Lehmann
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-20       Impact factor: 5.742

8.  Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.

Authors:  Diana X Nichols-Vinueza; Mark Parta; Nirali N Shah; Jennifer M Cuellar-Rodriguez; Thomas R Bauer; Robert R West; Amy P Hsu; Katherine R Calvo; Seth M Steinberg; Luigi D Notarangelo; Steven M Holland; Dennis D Hickstein
Journal:  Br J Haematol       Date:  2021-09-27       Impact factor: 8.615

Review 9.  Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Emilia J Kozyra; Marcin W Wlodarski
Journal:  Best Pract Res Clin Haematol       Date:  2020-07-29       Impact factor: 3.020

Review 10.  Lessons learned from the study of human inborn errors of innate immunity.

Authors:  Giorgia Bucciol; Leen Moens; Barbara Bosch; Xavier Bossuyt; Jean-Laurent Casanova; Anne Puel; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2018-08-01       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.